UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Epitope Discovery and Synthetic Vaccine Design

2018

Link zum Volltext

Verfügbarkeit prüfen

The Delay in the Licensing of Protozoal Vaccines: A Comparative History

Frontiers in immunology, 2020-03, Vol.11, p.204-204

2020

Link zum Volltext

Verfügbarkeit prüfen

Nucleoside Hydrolase NH 36: A Vital Enzyme for the Leishmania Genus in the Development of T-Cell Epitope Cross-Protective Vaccines

Frontiers in immunology, 2019-04, Vol.10, p.813-813

Palatnik-de-Sousa, Clarisa Beatriz

2019

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Epitope Discovery and Synthetic Vaccine Design

Frontiers in immunology, 2018-04, Vol.9, p.826-826

2018

Link zum Volltext

Verfügbarkeit prüfen

Portrait of an ISV Fellow

Human vaccines & immunotherapeutics, 2020-06, Vol.16 (6), p.1228-1231

Palatnik de Sousa, Clarisa Beatriz

2020

Link zum Volltext

Verfügbarkeit prüfen

A novel vaccine based on SARS-CoV-2 CD4 + and CD8 + T cell conserved epitopes from variants Alpha to Omicron

Scientific reports, 2022-10, Vol.12 (1), p.16731-21, Article 16731

2022

Link zum Volltext

Verfügbarkeit prüfen

Cross-Protective Efficacy of a Prophylactic Leishmania donovani DNA Vaccine against Visceral and Cutaneous Murine Leishmaniasis

Infection and Immunity, 2005-02, Vol.73 (2), p.812-819

2005

Link zum Volltext

Verfügbarkeit prüfen

The FML-vaccine (Leishmune ®) against canine visceral leishmaniasis: A transmission blocking vaccine

Vaccine, 2006-03, Vol.24 (13), p.2423-2431

2006

Link zum Volltext

Verfügbarkeit prüfen

NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis

Frontiers in immunology, 2018-05, Vol.9, p.967-967

2018

Link zum Volltext

Verfügbarkeit prüfen

Pulcherrimasaponin, from the leaves of Calliandra pulcherrima, as adjuvant for immunization in the murine model of visceral leishmaniasis

Vaccine, 2005-01, Vol.23 (8), p.1061-1071

2005

Link zum Volltext

Verfügbarkeit prüfen

Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis

Parasites & vectors, 2015-02, Vol.8 (1), p.111-111, Article 111

2015

Link zum Volltext

Verfügbarkeit prüfen

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

Vaccine, 2002-11, Vol.21 (1), p.30-43

2002

Link zum Volltext

Verfügbarkeit prüfen

Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani

Vaccine, 1997-06, Vol.15 (9), p.1024-1029

1997

Link zum Volltext

Verfügbarkeit prüfen

Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis

Frontiers in immunology, 2017-03, Vol.8, p.227-227

2017

Link zum Volltext

Verfügbarkeit prüfen

Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection

Frontiers in immunology, 2014, Vol.5, p.273-273

2014

Link zum Volltext

Verfügbarkeit prüfen

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine

Vaccine, 2004-06, Vol.22 (17), p.2234-2243

2004

Link zum Volltext

Verfügbarkeit prüfen

Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors

Parasites & vectors, 2012-11, Vol.5 (1), p.261-261, Article 261

2012

Link zum Volltext

Verfügbarkeit prüfen

The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains

Vaccine, 2012-05, Vol.30 (21), p.3169-3179

2012

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with Nucleoside Hydrolase (NH36) of L.(L.) Donovani or its C-terminal Portion (F3) in Formulation with Saponin Prevents the Increase of the Proportions of Spleen Dendritic Cells in Murine Experimental Visceral Leishmaniasis

Procedia in vaccinology, 2014, Vol.8, p.58-61

2014

Link zum Volltext

Verfügbarkeit prüfen

The adjuvanticity ofChiococca albasaponins increases with the length and hydrophilicity of their sugar chains

Vaccine, 2012-05, Vol.30 (21), p.3169

2012

Link zum Volltext

Verfügbarkeit prüfen

IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis

Vaccine, 2003-06, Vol.21 (19), p.2589-2597

2003

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine

Vaccine, 2003-12, Vol.21 (32), p.4668-4676

2003

Link zum Volltext

Verfügbarkeit prüfen

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

Vaccine, 2001-04, Vol.19 (23-24), p.3104-3115

2001

Link zum Volltext

Verfügbarkeit prüfen

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani

Vaccine, 1999-06, Vol.17 (20-21), p.2554-2561

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Englisch
(29)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epitope Discovery and Synthetic Vaccine Design

The Delay in the Licensing of Protozoal Vaccines: A Comparative History

Nucleoside Hydrolase NH 36: A Vital Enzyme for the Leishmania Genus in the Development of T-Cell Epitope Cross-Protective Vaccines

Editorial: Epitope Discovery and Synthetic Vaccine Design

Portrait of an ISV Fellow

A novel vaccine based on SARS-CoV-2 CD4 + and CD8 + T cell conserved epitopes from variants Alpha to Omicron

Cross-Protective Efficacy of a Prophylactic Leishmania donovani DNA Vaccine against Visceral and Cutaneous Murine Leishmaniasis

The FML-vaccine (Leishmune ®) against canine visceral leishmaniasis: A transmission blocking vaccine

NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis

Pulcherrimasaponin, from the leaves of Calliandra pulcherrima, as adjuvant for immunization in the murine model of visceral leishmaniasis

Prevalence of IgG Autoantibodies against GD3 Ganglioside in Acute Zika Virus Infection

Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani

Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis

Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine

Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors

The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains

Vaccination with Nucleoside Hydrolase (NH36) of L.(L.) Donovani or its C-terminal Portion (F3) in Formulation with Saponin Prevents the Increase of the Proportions of Spleen Dendritic Cells in Murine Experimental Visceral Leishmaniasis

The adjuvanticity ofChiococca albasaponins increases with the length and hydrophilicity of their sugar chains

IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis

Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani

Suchergebnisse filtern